Journal Reviews

Solifenacin and mirabegron are safe and effective in combination

1 September 2015 | | Functional Urology | Combination therapy, Mirabegron, Overactive bladder, Solifenacin

Antimuscarinic agents remain the mainstay of medical management of bladder overactivity. Limited somewhat by their tolerability, the new agent mirabegron, a β3-adrenoreceptor agonist, has been approved as an alternative. There is little known however about the possible synergistic effects of...